Compare top Chemotherapy for Sarcomas doctors and prices in Turkey. Find your best match here.
We'll hand-pick the best doctors based on your needs and budget.
Meet the experts behind this page
Medically reviewed by Fahad Mawlood
Medical Editor & Data ScientistTop doctors
1
Turkey
Reviews
14,000+
From real patients
Compare prices for Chemotherapy for Sarcomas across top countries
Tap a country to view top doctors and prices
Get free personalized treatment plans and choose the best option. No commitment · No payments for our services
Prof. Demirkaya specializes in pediatric oncology with over 27 years of experience of experience treating sarcomas at Medicana Bursa Hospital.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team
4300++ patient journeys guided
3 years at Bookimed
278 patients from Turkey have found their doctor through us this month
2 min Quiz
Tell us your goal, budget, timeline
Human Matching + AI
Our algorithm finds matches, coordinator verifies fit
Your Options Ready
Compare prices, packages, dates. Chat with your coordinator
Overwhelmed by choices?
Guiding your treatment
Medically trained personal coordinators
| Rank | Doctor | experience | Good Fit For | What Sets Them Apart | Clinic & Location | Consultation |
|---|---|---|---|---|---|---|
| #1 | 27 years of experience | Pediatric sarcomas | Specializes in pediatric oncology with extensive training and academic roles. Former professor at Bursa Uludag University. | Turkey | Price on request
|
Leading medical oncologists in Turkey for sarcoma chemotherapy include Dr. Bulent Karagoz and Dr. Yesim Yildirim. They practice at Anadolu Medical Center. These experts focus on targeted therapies. Some trained at top centers like MD Anderson. They treat bone and soft-tissue sarcomas within multidisciplinary teams.
Bookimed Expert Insight: Top Turkish oncologists often hold dual expertise that improves sarcoma care. Dr. Necdet Uskent is specialized in both oncology and hematology. This is vital for managing complex bone sarcomas. Dr. Bulent Karagoz leads the Medical Ethics Committee. This background is helpful when designing intensive chemotherapy protocols for rare tumor types. These doctors offer consultations starting from $100 up to approximately $215.
Patient Consensus: Patients note that successful sarcoma treatment depends on oncologists who work with specialized surgeons and pathologists. They emphasize that correct pathology review is essential before starting any chemotherapy cycles. Many felt more confident at large academic centers where tumor boards review each case.
When selecting a sarcoma oncologist in Turkey, verify Turkish Board certification in medical oncology and international credentials from ESMO or ASCO. Leading specialists like Dr. Bulent Karagoz and Dr. Yesim Yildirim often hold academic titles such as Professor and possess over 20+ years of clinical experience.
Bookimed Expert Insight: Data shows that Turkey’s leading sarcoma specialists often pursue dual international training and academic leadership. For example, Dr. Mustafa Solak trained at MD Anderson, while Dr. Necdet Uskent founded the Turkish Oncology Group. Patients should prioritize doctors with Professor titles at clinics having Johns Hopkins or ESMO accreditation for complex cases.
Patient Consensus: Patients emphasize that general oncology experience is not enough for this rare cancer. They recommend finding a specialist who coordinates closely with pathologists to ensure the exact sarcoma subtype is identified. Many noted feeling safer at hospitals where a tumor board reviews their specific chemotherapy plan.
International patients can consult Turkish sarcoma chemotherapy doctors by scheduling a remote video conference or requesting a written second opinion. Key oncologists specializing in sarcomas review medical records and pathology through digital channels to establish a treatment protocol before patients travel for care.
Bookimed Expert Insight: Data shows that sarcomas are frequently reviewed by oncologists with extensive academic backgrounds, such as Dr. Mustafa Solak, who trained at MD Anderson Cancer Center. Patients benefit from doctors who hold ECFMG or ESMO certifications and have published over 80+ research papers, ensuring the most current chemotherapy protocols for rare tumor subtypes.
Patient Consensus: Patients note it's important to organize all pathology reports and scans into one digital packet before starting. They say that having a written treatment plan in English helps them coordinate better with their local doctors later. Many mention that re-reading pathology slides is a standard step that can refine the final chemotherapy plan.
Turkish medical centers such as Anadolu Medical Center and Hisar Hospital Intercontinental provide specialized sarcoma chemotherapy through board-certified oncologists. Many experts hold European Society for Medical Oncology certifications. These hospitals utilize multidisciplinary tumor boards to manage rare bone and soft tissue tumors with targeted systemic therapies.
Bookimed Expert Insight: Data shows a high concentration of sarcoma expertise at Anadolu Medical Center, where specialists like Dr. Eda Tanrikulu and Dr. Yesim Yildirim work alongside experts who pioneered bone marrow transplants in Turkey. This institution is uniquely affiliated with Johns Hopkins Medicine, providing patients with access to international treatment protocols. Online consultations with these medical oncologists are available starting from $100 to $215.
Patient Consensus: Patients note it is vital to select large multidisciplinary centers that handle the entire diagnostic workup in-house. They emphasize that outcomes improved when medical and surgical oncology teams collaborated on their specific sarcoma subtypes. Many expressed relief that the clinics managed all translations and logistics during intensive chemotherapy cycles.
Turkish oncologists at leading medical centers utilize sarcoma chemotherapy protocols that strictly align with NCCN and ESMO standards. These specialists often undergo advanced training at premier Western institutions like MD Anderson Cancer Center. This ensures patients receive evidence-based drug regimens identical to those in the US and Europe.
Bookimed Expert Insight: A defining pattern in Turkey is the concentration of European-certified medical oncologists within single facilities. At Anadolu Medical Center, for example, multiple professors like Dr. Yesim Yildirim and Dr. Seref Komurcu hold the ESMO Medical Oncology Certificate. This high density of internationally validated expertise means patients benefit from a unified approach to complex sarcoma cases. Consultations with these specialists start from $100 to $215.
Patient Consensus: Patients note that treatment starts much faster in Turkey than in many Western regions. They emphasize the importance of having cases reviewed by a multidisciplinary tumor board. Many feel reassured when biopsy results are cross-checked by specialized oncology labs to confirm the protocol.
Turkish medical oncologists act as central coordinators within a sarcoma care team. They design systemic drug regimens and manage complex therapies. These ESMO-certified experts collaborate with orthopedic surgeons and radiologists. This teamwork helps target rare tumor subtypes and prevent recurrence effectively.
Bookimed Expert Insight: Leading Turkish oncologists often hold dual international training and academic leadership roles. For instance, Dr. Mustafa Solak at Hisar Hospital Intercontinental trained at MD Anderson Cancer Center. Meanwhile, Dr. Yesim Yildirim at Anadolu Medical Center has 20+ years of experience and UK oncology training. This international exposure allows them to implement latest global sarcoma protocols. Consultations with these specialized professors typically range from $100 to around $215.
Patient Consensus: Patients value oncologists who explain the specific rationale behind choosing neoadjuvant versus adjuvant cycles. They note that the best results come when doctors actively coordinate schedules with surgeons. Effective management of fatigue and infection risk is seen as vital for the journey.